NCT03155724

Brief Summary

The objective of this MultiPole Pacing (MPP) sub-study of the QP ExCELs study is to demonstrate that the MPP feature is effective by converting a percentage of cardiac resynchronization therapy (CRT) non-responders to responders. The MPP sub-study is a single-arm, multi-center, prospective trial within the ongoing QP ExCELs study (NCT02290028).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable heart-failure

Timeline
Completed

Started May 2017

Typical duration for not_applicable heart-failure

Geographic Reach
1 country

44 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 16, 2017

Completed
3 days until next milestone

Study Start

First participant enrolled

May 19, 2017

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 23, 2020

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

March 8, 2021

Completed
Last Updated

March 8, 2021

Status Verified

February 1, 2021

Enrollment Period

2.7 years

First QC Date

May 15, 2017

Results QC Date

January 18, 2021

Last Update Submit

February 16, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiac Resynchronization Therapy (CRT) Responder Status With the MPP Feature

    Count of participants who are classified as "Improved", where responder classification is derived from a clinical composite score (CCS) based on changes in New York Heart Association (NYHA) class, Heart Failure (HF) hospitalization, and cardiovascular death. Responder classification at 6 months (evaluated compared to MPP Enrollment Visit) : * "Improved" * No HF hospitalization or cardiovascular death, AND * NYHA class is improved * "Unchanged" * No HF hospitalization or cardiovascular death, AND * NYHA class is unchanged * "Worsened" * HF hospitalization or cardiovascular death has occurred, OR * NYHA class is worsened

    Enrollment to 6 Months

Secondary Outcomes (3)

  • Percentage of Participants Without MPP System Related Adverse Events Requiring Additional Invasive Intervention to Resolve at 6 Months.

    Enrollment to 6 Months

  • Clinical Composite Score (CCS) + Patient Global Assessment (PGA) Responder Status Utilizing a Modified CCS That Incorporates the PGA

    Enrollment to 6 Months

  • CCS Responder Status Utilizing an Expanded Responder Classification

    Enrollment to 6 Months

Study Arms (1)

MultiPole Pacing

EXPERIMENTAL

Traditional biventricular pacing CRT non-responders at the 3 or 6 month QP ExCELs study follow-up.

Device: MultiPole Pacing

Interventions

CRT non-responders are programmed with MultiPole pacing ON.

MultiPole Pacing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Currently enrolled in the ongoing QP ExCELs study
  • Successfully implanted with a BIOTRONIK Ilivia 7 HF-T QP family CRT-D system, or future-marketed CRT-D system with the MPP feature. Successful implantation is defined as having at least two LV pacing vectors with a measured pacing threshold of ≤ 5.0 V @ any pulse width (allowing for a minimum 2.5 V safety margin) without phrenic nerve stimulation at the final programmed pacing output at the time of enrollment into the MPP sub-study.
  • CRT Responder Assessment classification as "Worsened" or "Unchanged"
  • Standard continuous biventricular (BiV) pacing from implant until the 6-Month QP ExCELs follow-up visit. (Implant to 3-Month QP ExCELs follow-up who qualify due to a Heart Failure (HF) hospitalization event)
  • Able to understand the nature of the sub-study and give informed consent
  • Available for an additional follow-up visit specific to the MPP sub-study at the investigational site
  • No evidence of non-compliance to their ongoing commitment in the QP ExCELs study

You may not qualify if:

  • Have a life expectancy of less than 6 months
  • Expected to receive heart transplantation or ventricular assist device within 6 months
  • Chronic atrial fibrillation
  • Presence of another life-threatening, underlying illness separate from their cardiac disorder
  • Received MPP pacing prior to enrolment into the MPP sub-study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (44)

Thomas Hospital

Fairhope, Alabama, 36532, United States

Location

South Bay Electrophysiology

Inglewood, California, 90301, United States

Location

Eisenhower Desert Cardiology

Rancho Mirage, California, 92270, United States

Location

MedStar Washington Hospital Center

Washington D.C., District of Columbia, 20010, United States

Location

Florida Hospital

Orlando, Florida, 32803, United States

Location

Orlando Health Heart Institute

Orlando, Florida, 32806, United States

Location

Florida Hospital Tampa Pepin Heart Institute

Tampa, Florida, 33613, United States

Location

Piedmont Heart Institute

Atlanta, Georgia, 30309, United States

Location

University of Chicago Medical Center

Chicago, Illinois, 60637, United States

Location

Parkview Physicians Group - Cardiology

Fort Wayne, Indiana, 46845, United States

Location

University of Iowa Hospitals and Clinics

Iowa City, Iowa, 52242, United States

Location

University of Kansas Hospital

Kansas City, Kansas, 66160, United States

Location

Baptist Health - Lexington

Lexington, Kentucky, 40503, United States

Location

University of Kentucky

Lexington, Kentucky, 40536, United States

Location

Northeast Cardiology

Bangor, Maine, 04401, United States

Location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Southcoast Health

Fall River, Massachusetts, 02720, United States

Location

University of Massachusetts Medical School

Worcester, Massachusetts, 01655, United States

Location

University of Michigan Hospital

Ann Arbor, Michigan, 48109, United States

Location

Henry Ford Hospital

Detroit, Michigan, 48202, United States

Location

Michigan Heart

Ypsilanti, Michigan, 48197, United States

Location

Cardiology Associates of North Mississippi

Tupelo, Mississippi, 38801, United States

Location

SSM Health St. Joseph Hospital - St. Charles

Saint Charles, Missouri, 63301, United States

Location

Mercy Clinic Cardiology

Springfield, Missouri, 65804, United States

Location

St. Louis Heart and Vascular

St Louis, Missouri, 63136, United States

Location

Glacier View Medical Research Institute, Cardiology

Kalispell, Montana, 59901, United States

Location

Jersey Shore University Medical Center

Neptune City, New Jersey, 07753, United States

Location

New York Presbyterian Queens

Flushing, New York, 11355, United States

Location

Weill Cornell Medicine

New York, New York, 10021, United States

Location

Mt. Sinai St. Luke's Hospital

New York, New York, 10025, United States

Location

Montefiore Medical Center

The Bronx, New York, 10467, United States

Location

Westchester Medical Center

Valhalla, New York, 10595, United States

Location

Asheville Cardiology Associates

Asheville, North Carolina, 28803, United States

Location

Novant Health Winston-Salem Cardiology

Winston-Salem, North Carolina, 27103, United States

Location

Wake Forest Baptist Health Medical Center

Winston-Salem, North Carolina, 27157, United States

Location

Sanford Medical Center - Fargo

Fargo, North Dakota, 58102, United States

Location

University of Cincinnati

Cincinnati, Ohio, 45219, United States

Location

Temple Heart and Vascular Institute

Philadelphia, Pennsylvania, 19140, United States

Location

Upstate Cardiology

Greenville, South Carolina, 29607, United States

Location

UT Erlanger Cardiology

Chattanooga, Tennessee, 37403, United States

Location

Fort Worth Heart

Fort Worth, Texas, 76104, United States

Location

UT Health Science Center

The Woodlands, Texas, 77380, United States

Location

University of Utah Medical Center

Salt Lake City, Utah, 84132, United States

Location

UVM Medical

Burlington, Vermont, 05401, United States

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Results Point of Contact

Title
Clinical Studies Engineer Manager
Organization
BIOTRONIK

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2017

First Posted

May 16, 2017

Study Start

May 19, 2017

Primary Completion

January 23, 2020

Study Completion

January 23, 2020

Last Updated

March 8, 2021

Results First Posted

March 8, 2021

Record last verified: 2021-02

Locations